Memantine ER Maintains Patient Response in Moderate to Severe Alzheimer’s Disease: Post Hoc Analyses From a Randomized, Controlled, Clinical Trial of Patients Treated With Cholines...

por Grossberg, George T., Alva, Gustavo, Hendrix, Suzanne, Ellison, Noel, Kane, Mary C., Edwards, John
Publicado 2018

Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study

por Pivonello, Rosario, Bancos, Irina, Feelders, Richard A., Kargi, Atil Y., Kerr, Janice M., Gordon, Murray B., Mariash, Cary N., Terzolo, Massimo, Ellison, Noel, Moraitis, Andreas G.
Publicado 2021

Corrigendum: Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Ph...

por Pivonello, Rosario, Bancos, Irina, Feelders, Richard A., Kargi, Atil Y., Kerr, Janice M., Gordon, Murray B., Mariash, Cary N., Terzolo, Massimo, Ellison, Noel, Moraitis, Andreas G.
Publicado 2022

The Alzheimer’s Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer’s disease

por Langbaum, Jessica B., Ellison, Noel N., Caputo, Angelika, Thomas, Ronald G., Langlois, Carolyn, Riviere, Marie-Emmanuelle, Graf, Ana, Lopez Lopez, Cristina, Reiman, Eric M., Tariot, Pierre N., Hendrix, Suzanne B.
Publicado 2020